{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T04:12:57Z","timestamp":1750997577241,"version":"3.41.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Parkinson\u2019s disease (PD) is currently the fastest-growing neurological disorder in the world. Patients with PD face numerous challenges in managing their chronic condition, particularly in countries with scarce healthcare infrastructure.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective<\/jats:title>\n<jats:p>This qualitative study aimed to delve into neurologists\u2019 perspectives on challenges and gaps in the Iraqi healthcare system that influence the management of PD, as well as strategies to mitigate these obstacles.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method<\/jats:title>\n<jats:p>Semi-structured interviews were conducted with neurologists from five different Iraqi provinces, working in both hospitals and private neurology clinics, between November 2024 and January 2025. A thematic analysis approach was employed to identify the main challenges and gaps in the healthcare system, along with potential mitigation strategies for improving PD management in Iraq.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Fourteen neurologists participated in this study. Among them, 71.4% identified medication adherence as a major challenge, followed by motor symptoms (64.3%). Physical dependency due to motor impairment was the most reported limitation affecting daily life and disease management. Neurologists cited several factors influencing patients\u2019 knowledge, including educational background, depression or family support, were mentioned by neurologists. Significant gaps in the Iraqi healthcare system were noted, such as the lack of specialized abnormal movement disorders clinics, multidisciplinary collaboration, a universal healthcare system, insufficient public PD awareness, and the presence of unregulated pharmaceuticals in the market.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Addressing these challenges requires policy-driven reforms, enhanced regulatory oversight and the integration of multidisciplinary care frameworks to optimize the management of individuals with PD. Strengthening patient education and professional training programs could further raise public awareness and improve care quality. Future research should focus on evaluating the effects of these proposed interventions on clinical outcomes for PD patients and promoting more patient-centered care for individuals with PD in Iraq.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0326851","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:24:17Z","timestamp":1750958657000},"page":"e0326851","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neurologists\u2019 perspectives on management challenges and mitigation strategies for Parkinson\u2019s disease patients: A qualitative study in Iraq"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7350-3180","authenticated-orcid":true,"given":"Mena Khalid","family":"Ibrahim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7073-9976","authenticated-orcid":true,"given":"Samer Imad","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gheyath Abd Ali Shallal","family":"Al-Gawwam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"pone.0326851.ref001","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"ER Dorsey","year":"2018","journal-title":"J Parkinsons Dis"},{"issue":"11","key":"pone.0326851.ref002","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S1474-4422(17)30299-5","article-title":"Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the global burden of disease study 2015","volume":"16","author":"VL Feigin","year":"2017","journal-title":"Lancet Neurol"},{"issue":"2","key":"pone.0326851.ref003","article-title":"Spectrum of non-motor symptoms in Parkinson\u2019s disease","volume":"13","author":"M Kumaresan","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"pone.0326851.ref004","doi-asserted-by":"crossref","first-page":"122","DOI":"10.47723\/kcmj.v13i1.141","article-title":"Non motor symptoms in patients with Parkinson\u2019s disease in Baghdad hospitals","volume":"13","author":"AT Muslim","year":"2017","journal-title":"Al-Kindy Col Med J"},{"issue":"4","key":"pone.0326851.ref005","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/jnnp.2007.131045","article-title":"Parkinson\u2019s disease: clinical features and diagnosis","volume":"79","author":"J Jankovic","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"pone.0326851.ref006","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"E Tolosa","year":"2021","journal-title":"Lancet Neurol"},{"issue":"5","key":"pone.0326851.ref007","doi-asserted-by":"crossref","first-page":"813","DOI":"10.3390\/jpm12050813","article-title":"Personalized care in late-stage Parkinson\u2019s disease: challenges and opportunities","volume":"12","author":"M Fabbri","year":"2022","journal-title":"J Pers Med"},{"issue":"4","key":"pone.0326851.ref008","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3233\/JPD-212735","article-title":"Barriers to accessing healthcare services for people with Parkinson\u2019s disease: a scoping review","volume":"11","author":"MS Zaman","year":"2021","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"pone.0326851.ref009","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/mdc3.12200","article-title":"Barriers and facilitators in physical rehabilitation for Parkinson\u2019s disease in the Arabian world","volume":"2","author":"H Khalil","year":"2015","journal-title":"Mov Disord Clin Pract"},{"issue":"2","key":"pone.0326851.ref010","first-page":"179","article-title":"Prevalence of Parkinson\u2019s disease in Al-Kadihymia district (Baghdad city): community-based study","volume":"4","author":"AA Mutalib Kareem","year":"2005","journal-title":"Iraqi J Med Sci"},{"issue":"2","key":"pone.0326851.ref011","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3233\/JPD-191751","article-title":"Parkinson\u2019s Disease in the Middle East, North Africa, and South Asia: consensus from the international parkinson and movement disorder society task force for the middle east","volume":"10","author":"H Khalil","year":"2020","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"pone.0326851.ref012","first-page":"289","article-title":"Toward a healthier Iraq","volume":"87","author":"TKY Al Hilfi","year":"2014","journal-title":"Yale J Biol Med"},{"issue":"9915","key":"pone.0326851.ref013","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(13)62299-0","article-title":"Changing therapeutic geographies of the Iraqi and Syrian wars","volume":"383","author":"O Dewachi","year":"2014","journal-title":"Lancet"},{"issue":"2","key":"pone.0326851.ref014","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/jfcm.jfcm_362_22","article-title":"Performance evaluation of health houses in Iraq 2021-2022: a descriptive study","volume":"30","author":"MA Al-Ashbal","year":"2023","journal-title":"J Family Community Med"},{"issue":"8","key":"pone.0326851.ref015","article-title":"Parkinson disease: an overview for the management techniques via physical therapy","volume":"3","author":"AAH Alameer","year":"2024","journal-title":"JoE"},{"issue":"9","key":"pone.0326851.ref016","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1212\/WNL.0b013e31822c9123","article-title":"Neurologist care in Parkinson disease: a utilization, outcomes, and survival study","volume":"77","author":"AW Willis","year":"2011","journal-title":"Neurology"},{"issue":"2","key":"pone.0326851.ref017","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"V Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"3","key":"pone.0326851.ref018","doi-asserted-by":"crossref","first-page":"161","DOI":"10.31351\/vol33iss3pp161-170","article-title":"Serum level of S100B protein as a biomarker of therapeutic adherence in Parkinson\u2019s disease patients","volume":"33","author":"MR Oglah","year":"2024","journal-title":"Iraqi J Pharm Sci"},{"issue":"1","key":"pone.0326851.ref019","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1186\/s12889-024-18431-y","article-title":"Medication adherence and costs of medical care among patients with Parkinson\u2019s disease: an observational study using electronic medical records","volume":"24","author":"Z Yi","year":"2024","journal-title":"BMC Public Health"},{"issue":"10","key":"pone.0326851.ref020","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.26719\/emhj.21.025","article-title":"Pharmaceutical regulations in Iraq: from medicine approval to postmarketing","volume":"27","author":"AA Al-Jumaili","year":"2021","journal-title":"East Mediterr Health J"},{"issue":"10","key":"pone.0326851.ref021","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1080\/09593985.2023.2236691","article-title":"The quality of life in individuals with Parkinson\u2019s disease: is it related to functionality and tremor severity? A cross-sectional study","volume":"40","author":"B Kilinc","year":"2024","journal-title":"Physiother Theory Pract"},{"key":"pone.0326851.ref022","doi-asserted-by":"crossref","DOI":"10.1002\/mdc3.13786","article-title":"Beyond the dopaminergic system: lessons learned from levodopa resistant symptoms in Parkinson\u2019s disease","volume":"10","author":"A Antonini","year":"2023","journal-title":"Mov Disord Clin Pract"},{"key":"pone.0326851.ref023","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/bs.irn.2017.05.023","article-title":"Quality of life and nonmotor symptoms in Parkinson\u2019s disease","volume":"133","author":"P Barone","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"pone.0326851.ref024","doi-asserted-by":"crossref","first-page":"105","DOI":"10.12799\/jkachn.2022.33.1.105","article-title":"The effect of depression on quality of life in patients with Parkinson\u2019s disease: mediating effect of family function","volume":"33","author":"ES Bae","year":"2022","journal-title":"J Korean Acad Community Health Nurs"},{"issue":"9","key":"pone.0326851.ref025","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jagp.2019.03.002","article-title":"The Neuropsychiatry of Parkinson disease: a perfect storm","volume":"27","author":"D Weintraub","year":"2019","journal-title":"Am J Geriatr Psychiatry"},{"key":"pone.0326851.ref026","doi-asserted-by":"crossref","first-page":"283","DOI":"10.31351\/vol32issSuppl.pp283-290","article-title":"The perceptions of general population about mental health services in Baghdad, Iraq: a qualitative study","volume":"32","author":"ZS Jumaah","year":"2023","journal-title":"IJPS"},{"issue":"4","key":"pone.0326851.ref027","doi-asserted-by":"crossref","first-page":"660","DOI":"10.4103\/aian.aian_779_21","article-title":"Annual cost of care of Parkinson\u2019s disease and its determinants in North India - a cost of illness study with patient perspective","volume":"25","author":"V Ola","year":"2022","journal-title":"Ann Indian Acad Neurol"},{"key":"pone.0326851.ref028","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jns.2016.12.063","article-title":"Knowledge, attitudes and perceptions of Parkinson\u2019s disease: a cross-sectional survey of Asian patients","volume":"374","author":"O Jitkritsadakul","year":"2017","journal-title":"J Neurol Sci"},{"key":"pone.0326851.ref029","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4103\/ijpvm.IJPVM_221_19","article-title":"Predictors and level of knowledge regarding Parkinson\u2019s disease among patients: a cross-sectional study from Thailand","volume":"11","author":"P Viwattanakulvanid","year":"2020","journal-title":"Int J Prev Med"},{"issue":"1","key":"pone.0326851.ref030","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1186\/s12889-024-20620-8","article-title":"Parkinson\u2019s disease in the Lebanese population: knowledge and attitude scales\u2019 validation and correlates","volume":"24","author":"S Abramian","year":"2024","journal-title":"BMC Public Health"},{"key":"pone.0326851.ref031","first-page":"100038","article-title":"Patient perceptions and knowledge of Parkinson\u2019s disease and treatment (KnowPD)","volume":"3","author":"MR Salinas","year":"2020","journal-title":"Clin Park Relat Disord"},{"issue":"4","key":"pone.0326851.ref032","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2217\/nmt-2017-0014","article-title":"Treatment gaps in Parkinson\u2019s disease care in the Philippines","volume":"7","author":"RDG Jamora","year":"2017","journal-title":"Neurodegener Dis Manag"},{"issue":"2","key":"pone.0326851.ref033","doi-asserted-by":"crossref","first-page":"209","DOI":"10.32007\/jfacmedbagdad.6622070","article-title":"Proportion and potential risk factors of poor glycemic control among patients with Type 2 Diabetes mellitus: experience of a tertiary center in Baghdad, Iraq, 2020","volume":"66","author":"ZA Zaboon Al-Majidi","year":"2024","journal-title":"J Fac Med Baghdad"},{"issue":"2","key":"pone.0326851.ref034","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1055\/s-0044-1779608","article-title":"The impact of the socioeconomic factor on Parkinson\u2019s disease medication adherence: a scoping review","volume":"82","author":"G Gil","year":"2024","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"pone.0326851.ref035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/med4.70005","article-title":"Alone in the mind: review of research examining the link between loneliness and dementia","volume":"3","author":"AH Al\u2010Samiry","year":"2025","journal-title":"Med Adv"},{"key":"pone.0326851.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09638288.2024.2447379","article-title":"Social factors related to participation among people with Parkinson\u2019s disease","author":"MY Kim","year":"2024","journal-title":"Disabil Rehabil"},{"issue":"5","key":"pone.0326851.ref037","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3390\/medicina60050711","article-title":"General treatments promoting independent living in Parkinson\u2019s patients and physical therapy approaches for improving Gait-A comprehensive review","volume":"60","author":"D-H Lee","year":"2024","journal-title":"Medicina (Kaunas)"},{"issue":"2","key":"pone.0326851.ref038","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/jsan14020023","article-title":"Application of wearable sensors in Parkinson\u2019s disease: state of the art","volume":"14","author":"A Bougea","year":"2025","journal-title":"J Sens Actuator Netw"},{"key":"pone.0326851.ref039","doi-asserted-by":"crossref","first-page":"204","DOI":"10.31351\/vol32issSuppl.pp204-213","article-title":"Professional challenges facing pharmacists working at public hospitals in an iraqi province: a qualitative study","volume":"32","author":"Z Nassrullah","year":"2023","journal-title":"Iraqi J Pharm Sci"},{"issue":"2","key":"pone.0326851.ref040","first-page":"57","article-title":"The role of a movement disorders clinic","volume":"105","author":"J Yssel","year":"2012","journal-title":"Ir Med J"},{"key":"pone.0326851.ref041","doi-asserted-by":"crossref","first-page":"131","DOI":"10.31351\/vol31issSuppl.pp131-140","article-title":"The insights of experienced pharmacists regarding the iraqi health insurance program: a qualitative study","volume":"31","author":"AA Al-Jumaili","year":"2023","journal-title":"Iraqi J Pharm Sci"},{"issue":"4","key":"pone.0326851.ref042","doi-asserted-by":"crossref","first-page":"166","DOI":"10.31351\/vol33iss4pp166-173","article-title":"Impact of clinical pharmacist-led interventions on short term quality of life among breast cancer women taking chemotherapy","volume":"33","author":"KH Alkashaf","year":"2024","journal-title":"Iraqi J Pharm Sci"},{"issue":"1","key":"pone.0326851.ref043","doi-asserted-by":"crossref","first-page":"256","DOI":"10.31351\/vol34iss1pp256-265","article-title":"Impact of clinical pharmacist-led interventions on short term quality of life among multiple sclerosis patients taking disease-modifying therapy","volume":"34","author":"Z Abbas Munaf","year":"2025","journal-title":"Iraqi J Pharm Sci"},{"key":"pone.0326851.ref044","doi-asserted-by":"crossref","DOI":"10.1177\/20503121241275472","article-title":"Perception, experience, and practice of Iraqi community pharmacists towards customers with substance use disorder","volume":"12","author":"EM Mikhael","year":"2024","journal-title":"SAGE Open Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0326851","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T17:24:25Z","timestamp":1750958665000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0326851"}},"subtitle":[],"editor":[{"given":"Ioannis","family":"Liampas","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0326851","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}